Buzz: Will Brent Saun­ders split up Al­ler­gan if he los­es the Resta­sis patent fight?

With its stock trad­ing south of $200 af­ter the big Resta­sis set­back on the patent front, you can hear the grow­ing buzz of an­a­lysts ea­ger­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.